Co-Diagnostics, Inc. Quarterly Debt-to-equity in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Co-Diagnostics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q3 2024.
  • Co-Diagnostics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 11.5 %, a 46.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 11.5 +3.66 +46.8% Sep 30, 2024
Q2 2024 10.4 +2.42 +30.2% Jun 30, 2024
Q1 2024 9.85 +1.09 +12.4% Mar 31, 2024
Q4 2023 8.57 -2.74 -24.2% Dec 31, 2023
Q3 2023 7.82 -6.11 -43.8% Sep 30, 2023
Q2 2023 8.02 -5.37 -40.1% Jun 30, 2023
Q1 2023 8.76 -3.96 -31.1% Mar 31, 2023
Q4 2022 11.3 +0.98 +9.48% Dec 31, 2022
Q3 2022 13.9 +7.84 +129% Sep 30, 2022
Q2 2022 13.4 +7.46 +126% Jun 30, 2022
Q1 2022 12.7 +6.52 +105% Mar 31, 2022
Q4 2021 10.3 +4.14 +66.9% Dec 31, 2021
Q3 2021 6.09 -0.06 -0.98% Sep 30, 2021
Q2 2021 5.94 -2.96 -33.3% Jun 30, 2021
Q1 2021 6.2 -3.38 -35.3% Mar 31, 2021
Q4 2020 6.19 -6.93 -52.8% Dec 31, 2020
Q3 2020 6.15 -26.7 -81.3% Sep 30, 2020
Q2 2020 8.9 -57.5 -86.6% Jun 30, 2020
Q1 2020 9.58 -101 -91.3% Mar 31, 2020
Q4 2019 13.1 -219 -94.4% Dec 31, 2019
Q3 2019 32.9 -29.9 -47.6% Sep 30, 2019
Q2 2019 66.4 +41.8 +170% Jun 30, 2019
Q1 2019 110 +9.07 +8.96% Mar 31, 2019
Q4 2018 232 Dec 31, 2018
Q3 2018 62.8 Sep 30, 2018
Q2 2018 24.6 Jun 30, 2018
Q1 2018 101 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.